You just read:

AcelRX Pharmaceuticals Announces Presentation Of Phase 3 Sufentanil Sublingual 30mcg Tablet Data At The European Society Of Emergency Medicine Meeting

News provided by

AcelRx Pharmaceuticals, Inc.

Oct 09, 2015, 07:00 ET